Understanding weight loss in advanced cancer
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at how weight loss and muscle loss affect people with advanced cancer. It aims to find different types of weight loss to better guide treatment and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with advanced (stage 4) non-small cell lung, pancreatic, or colorectal cancer.
- You are planning to start or have just started your first cancer treatment (like chemo or immunotherapy) for this cancer.
- You have an ECOG performance status of 0, 1, or 2.
- You are 18 years or older and can read and speak English.
- You are not pregnant and do not have any planned major surgeries in the next 3 months.
- You do not have any other active cancer (except for non-melanoma skin cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different types of weight loss (cachexia) in people with advanced lung, pancreatic, or colorectal cancer. Researchers want to find patterns to better understand and treat it. You can join even if you haven't lost weight yet.
This study looks at why cancer can cause loss of muscle in people with advanced non–small cell lung cancer, and whether exercise can improve or explain those muscle changes. You may be asked to do physical testing and answer questionnaires while receiving standard palliative cancer treatment.
This trial tests whether a postbiotic supplement can help people with advanced non-small-cell lung cancer who are losing weight (cachexia). If you're getting or have finished chemotherapy plus immunotherapy for stage III or IV NSCLC and have lost weight recently, you may be able to join.
This trial tests a new appetite-boosting medicine (nano-crystalline megestrol acetate) added to standard chemotherapy for people with advanced small cell lung cancer who are losing weight. It aims to see if it helps with weight, strength, and treatment response.
This trial tests a “multimodal” program meant to help people with cancer avoid developing cachexia, a condition that causes unwanted weight and muscle loss. It may help you stay stronger and maintain weight if you are not yet in advanced or rapidly worsening stages.
This study tests if low-dose CT scans can find early lung cancer in people who have unexplained weight loss. It aims to see if weight loss could be a sign that makes screening more useful.
Hear when a new Advanced Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.